Blue Fin Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-2,819
| Closed | -$335K | – | 145 |
|
2024
Q2 | $335K | Buy |
2,819
+23
| +0.8% | +$2.73K | 0.07% | 117 |
|
2024
Q1 | $298K | Buy |
2,796
+568
| +25% | +$60.5K | 0.07% | 120 |
|
2023
Q4 | $222K | Buy |
+2,228
| New | +$222K | 0.06% | 134 |
|
2023
Q3 | – | Sell |
-1,849
| Closed | -$225K | – | 130 |
|
2023
Q2 | $225K | Buy |
1,849
+40
| +2% | +$4.86K | 0.06% | 128 |
|
2023
Q1 | $243K | Buy |
1,809
+42
| +2% | +$5.64K | 0.08% | 122 |
|
2022
Q4 | $317K | Sell |
1,767
-99
| -5% | -$17.8K | 0.12% | 106 |
|
2022
Q3 | $220K | Buy |
1,866
+11
| +0.6% | +$1.3K | 0.08% | 119 |
|
2022
Q2 | $264K | Sell |
1,855
-105
| -5% | -$14.9K | 0.09% | 114 |
|
2022
Q1 | $337K | Buy |
1,960
+514
| +36% | +$88.4K | 0.1% | 103 |
|
2021
Q4 | $367K | Buy |
1,446
+715
| +98% | +$181K | 0.1% | 101 |
|
2021
Q3 | $281K | Buy |
+731
| New | +$281K | 0.09% | 110 |
|